Jaume Reventos

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-β1 and NF-κB pathways.

Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-β1 and NF-κB pathways.

Journal: Frontiers in oncology
Published: October 18, 2023

Editorial: Artificial intelligence: A step forward in biomarker discovery and integration towards improved cancer diagnosis and treatment.

Editorial: Artificial intelligence: A step forward in biomarker discovery and integration towards improved cancer diagnosis and treatment.

Journal: Frontiers in oncology
Published: February 07, 2023

An Integrated Approach for the Early Detection of Endometrial and Ovarian Cancers (Screenwide Study): Rationale, Study Design and Pilot Study.

An Integrated Approach for the Early Detection of Endometrial and Ovarian Cancers (Screenwide Study): Rationale, Study Design and Pilot Study.

Journal: Journal of personalized medicine
Published: May 30, 2022

Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples.

Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples.

Journal: Cancers
Published: November 21, 2021

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways.

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways.

Journal: Frontiers in oncology
Published: August 12, 2019

Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools.

Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools.

Journal: Oncology reports
Published: August 01, 2019

New perspectives on screening and early detection of endometrial cancer.

New perspectives on screening and early detection of endometrial cancer.

Journal: International journal of cancer
Published: February 15, 2019

Defining a mutational signature for endometrial cancer screening and early detection.

Defining a mutational signature for endometrial cancer screening and early detection.

Journal: Cancer epidemiology
Published: November 09, 2018

Characterization of the molecular changes associated with the overexpression of a novel epithelial cadherin splice variant mRNA in a breast cancer model using proteomics and bioinformatics approaches: identification of changes in cell metabolism and an increased expression of lactate dehydrogenase B.

Characterization of the molecular changes associated with the overexpression of a novel epithelial cadherin splice variant mRNA in a breast cancer model using proteomics and bioinformatics approaches: identification of changes in cell metabolism and an increased expression of lactate dehydrogenase B.

Journal: Cancer & metabolism
Published: October 31, 2018

MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways.

MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways.

Journal: Oncogene
Published: August 28, 2018

Advances in endometrial cancer protein biomarkers for use in the clinic.

Advances in endometrial cancer protein biomarkers for use in the clinic.

Journal: Expert review of proteomics
Published: November 30, 2017

ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer.

ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer.

Journal: Oncotarget
Published: October 26, 2017
Showing 1-12 of 49

Last Updated: 09/26/2026